Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
Abstract The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of a...
Saved in:
Main Authors: | James J. Hoy, Georgios Kallifatidis, Diandra K. Smith, Bal L. Lokeshwar |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/d694f9f3e8db41efa65a4e39eb7119d8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
by: N. V. Kipich, et al.
Published: (2014) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
by: Aasems Jacob, et al.
Published: (2021) -
Androgen receptor-binding sites are highly mutated in prostate cancer
by: Tunç Morova, et al.
Published: (2020) -
Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10
by: Weiyuan Li, et al.
Published: (2021) -
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
by: Emma Hörnberg, et al.
Published: (2011)